---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-059004"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T16:27:59.626842+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics receives Nasdaq minimum bid price non-compliance notice

## Summary
- Nasdaq notified company on June 23, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until December 22, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, company may qualify for an additional 180-day period if it meets other listing requirements and intends to effect a reverse stock split.
- Company is evaluating options; notice does not affect business operations or SEC reporting obligations.

## SEC filing metadata
- accession: 0001213900-25-059004
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390025059004/0001213900-25-059004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390025059004/ea0246913-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-059004
- JSON: https://secwatch.observer/filing/0001213900-25-059004.json
- Plain text: https://secwatch.observer/filing/0001213900-25-059004.txt

## Key facts
- Listing & Compliance Notices
  Pasithea Therapeutics Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: June 23, 2025, Pasithea Therapeutics Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841330/000121390025059004/0001213900-25-059004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.